Tissue Repair & Regeneration
Argireline (Acetyl Hexapeptide-3)

Last updated
Manufacturer’s claim vendor marketing
For a proprietary cosmetic ingredient the manufacturer is the originator — there is no upstream to defer to, and this is often the only description that exists. It is reproduced as an attributed claim, with the label its source gave it. It is not graded and it is not evidence — the graded studies are under Literature.
Vendor claim (ci.guide): "Botox-like" effect; smoothing action; humectant properties; relaxes facial muscles by destabilizing SNARE complex formation, reducing muscle contraction and attenuating wrinkle formation. No n= or study duration given on fetched page.
- Manufacturer
- Lipotec SA (now part of Lubrizol)
- Sold as
- Argireline
Source page — nofollow, because a vendor link is a reference here, not an endorsement.
Dosing on file unverified
10% solution, 2x/day (30 days); 5-10% in serums
Carried from a source that labels it unverified, and reproduced with that label attached. A record of what is reported, not a recommendation. No citation on this page establishes it.
Literature on file 4
-
human observational
NCT01750346: Placebo Controlled Double Blind Study of Acetyl Hexapeptide-8 in Treatment of Blepharospasm graded on: a registered clinical study — “clinicaltrials.gov”
-
human observational
NCT01381484: Efficacy and Safety of Topical Argireline in the Treatment of Periorbital Wrinkles graded on: a registered clinical study — “clinicaltrials.gov”
Not graded
2 citations whose study design could not be read from the title. Left ungraded rather than guessed at.
- not graded
- not graded
Identity
Skeletal formulathe canonical depiction
Drawn by PubChem from CID 71587772, the identifier on this record.
- Molecular weight
- 887.0
- Molecular formula
- C35H62N14O11S
- CAS number
- 616204-22-9
- PubChem CID
- 71587772
- InChI key
- AJLNZWYOJAWBCR-OOPVGHQCSA-N
- SMILES
- CC(=O)N[C@@H](CCC(=O)O)C(=C)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N
- InChI
- InChI=1S/C35H62N14O11S/c1-18(20(45-19(2)50)9-12-27(52)53)44-23(10-13-28(54)55)31(58)49-25(14-17-61-3)33(60)48-24(8-11-26(36)51)32(59)47-22(7-5-16-43-35(40)41)30(57)46-21(29(37)56)6-4-15-42-34(38)39/h20-25,44H,1,4-17H2,2-3H3,(H2,36,51)(H2,37,56)(H,45,50)(H,46,57)(H,47,59)(H,48,60)(H,49,58)(H,52,53)(H,54,55)(H4,38,39,42)(H4,40,41,43)/t20-,21-,22-,23-,24-,25-/m0/s1
Also called
- Acetyl Hexapeptide-8
- Argireline
Caveat on these identifiers
Registry record names acetyl hexapeptide-8 (an alternate INCI name for Argireline).
Notes unverified prose
2002 pivotal study: 30% wrinkle reduction (30 days, 10% solution); 17-30% wrinkle depth reduction; NCT01750346; NCT01381484; 2002 pivotal study (30% wrinkle reduction)
Not on file 1
1 of the 8 fields we track hold nothing on this record, and each says why. A blank field is a bug; a named absence is a finding.
- amino-acid sequencenothing we hold supplies it
Each field links to every other record missing the same thing. The full ledger holds 521 gaps across 136 records.